mRESVIA won approval based on the Phase III ConquerRSV trial, a global study of around 37,000 adults aged 60 or older in 22 countries, in which it displayed an efficacy rate of 83.7% against RSV lower respiratory tract disease
However, if you are looking to target a specific area, here is how to decide
There is no established direct causal link between Rybelsus and peptic ulcer disease in clinical trials or post-marketing surveillance
Knop, MD, PhD, professor of endocrinology and director of the Center for Clinical Metabolic Research at Gentofte Hospital at the University of Copenhagen, explained how these results might affect patient care going forward and what additional research is needed
A nodule that is growing, becoming significantly more painful, or persisting well past a week is worth recording and bringing to your providers attention